PubMed, Bottema, Renske W
Additionally, two small studies in participants presenting with antiretroviral-induced neuropathy found significant reduction in subjects' mean pain intensity with oral ALCAR (1-3 g/day) for 4 to 24 weeks, but no effect on objective neurophysiological parameters was found (82, 83)
Administration schedule: Once-daily subcutaneous injection
Things like FDA approval, doctor support, medication format, and pharmacy quality all matter and should be considered before deciding
Part of the issue would of course be a pharmacy issue, but given how well-known the pharmacy issues are, the licensing board could take disciplinary action against the provider
Sample Available: Samples are available for quality verification before placing bulk orders